Login / Signup

High-level production of recombinant HBcAg virus-like particles in a mathematically modelled P. pastoris GS115 Mut + bioreactor process under controlled residual methanol concentration.

Emils BolmanisOskars GrigsAndris KazaksVytautas Galvanauskas
Published in: Bioprocess and biosystems engineering (2022)
Recombinant hepatitis B core antigen (HBcAg) molecules, produced in heterologous expression systems, self-assemble into highly homogenous and non-infectious virus-like particles (VLPs) that are under extensive research for biomedical applications. HBcAg production in the methylotrophic yeast P. pastoris has been well documented; however, productivity screening under various residual methanol levels has not been reported for bioreactor processes. HBcAg production under various excess methanol levels of 0.1, 1.0 and 2.0 g L -1 was investigated in this research. Results indicate that, under these particular conditions, the total process and specific protein yields of 876-1308 mg L -1 and 7.9-11.2 mg g DCW -1 , respectively, were achieved after 67-75 h of cultivation. Produced HBcAg molecules were efficiently purified and the presence of highly immunogenic, correctly formed and homogenous HBcAg-VLPs with an estimated purity of 90% was confirmed by electron microscopy. The highest reported HBcAg yield of 1308 mg L -1 and 11.2 mg g DCW -1 was achieved under limiting residual methanol concentration, which is about 2.5 times higher than the next highest reported result. A PI-algorithm-based residual methanol concentration feed rate controller was employed to maintain a set residual methanol concentration. Finally, mathematical process models to characterise the vegetative, dead and total cell biomass (X v , X d and X), substrate (Glycerol and Methanol) concentration, reactor volume (V), and product (HBcAg) dynamics during cultivation, were identified. A rare attempt to model the residual methanol concentration during induction is also presented.
Keyphrases
  • carbon dioxide
  • wastewater treatment
  • poor prognosis
  • machine learning
  • mesenchymal stem cells
  • climate change
  • single cell
  • amino acid
  • cell therapy
  • anaerobic digestion